Science Explorer Interactive view Map
Company · Jerusalem · Israel

Immunovative Therapies (Israel)

Research works
5
▲ 202% vs 2013–17
Citations
53
11.0 per fractional work
Top-10% rate
3.5%
record average 16.5%
Open access
36%
world 28%

Not ranked overall: Immunovative Therapies (Israel) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Immunovative Therapies (Israel) publish most on?

By volume: Immunotherapy and Immune Responses, Immune Cell Function and Interaction, T-cell and B-cell Immunology and interferon and immune responses.

  1. 1 Immunotherapy and Immune Responses Immunology 1 works
  2. 2 Immune Cell Function and Interaction Immunology 0 works
  3. 3 T-cell and B-cell Immunology Immunology 0 works
  4. 4 interferon and immune responses Immunology 0 works
  5. 5 Respiratory viral infections research Epidemiology 0 works
  6. 6 Immune cells in cancer Immunology 0 works
  7. 7 Cancer Immunotherapy and Biomarkers Oncology 0 works
  8. 8 Cancer Research and Treatments Biotechnology 0 works
  9. 9 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 0 works
  10. 10 Hepatitis B Virus Studies Epidemiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.1%not open63.9%

World: 28% of research is openly available.

with international co-authors58.7%domestic only41.3%

World: 19% is written across borders.

How has Immunovative Therapies (Israel)'s research output changed?

Output in 2018–2022 was 202% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Jerusalem

All research institutions in Jerusalem

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.